Vivos Therapeutics (VVOS) Share-based Compensation Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.56% |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 766.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.19% |
| Dec 31, 2025 | -14.00% |
| Sep 30, 2025 | 833.33% |
| Jun 30, 2025 | -96.00% |
| Mar 31, 2025 | 8.19% |
| Dec 31, 2024 | 110.95% |
| Sep 30, 2024 | 50.00% |
| Jun 30, 2024 | 1,775.00% |
| Mar 31, 2024 | -4.25% |
| Dec 31, 2023 | -217.81% |
| Sep 30, 2023 | -50.00% |
| Jun 30, 2023 | -42.86% |
| Mar 31, 2023 | -49.75% |
| Dec 31, 2022 | -70.62% |
| Sep 30, 2022 | -63.64% |
| Jun 30, 2022 | 16.67% |
| Mar 31, 2022 | 40.32% |
| Dec 31, 2021 | 65.07% |
| Sep 30, 2021 | 156.61% |
| Jun 30, 2021 | 6.12% |